Effect of heat exposure on aminophylline-induced convulsions in mice

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 5, 2011, Pages 666-670

  Ochi, Rika ^a   Suemaru, Katsuya ^b   Watanabe, Shinichi ^b   Yamaguchi, Takumi ^c   Takechi, Kenshi ^a   Kawasaki, Hiromu ^a   Araki, Hiroaki ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MATSUYAMA UNIVERSITY   (Japan)

Author keywords

Convulsion; Gamma aminobutyric acidA receptor; Hyperthermia; N methyl D aspartic acid receptor; Theophylline

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMINOPHYLLINE; DIZOCILPINE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE MEASUREMENT; CONTROLLED STUDY; FEBRILE CONVULSION; HYPERTHERMIA; MALE; MOUSE; NONHUMAN; THEOPHYLLINE BLOOD LEVEL; THERMAL EXPOSURE;

AMINOPHYLLINE; ANIMALS; DIZOCILPINE MALEATE; FEVER; MALE; MICE; MUSCIMOL; SEIZURES; THEOPHYLLINE;

EID: 79955667007     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.666     Document Type: Article

References (22)

1. Korematsu S., Miyahara H., Nagakura T., Suenobu S., Izumi T., Pediatr. Int., 50, 95-98 (2008).
2. Zaccara G., Muscas G. C., Messori A., Drug Saf., 5, 109-151 (1990).
3. Nishima S., Arerugi, 55, 781-790 (2006).
4. Sierra-Paredes G., Sierra-Marcuno G., CNS Neurol. Disord. Drug Targets, 6, 288-300 (2007).
5. Ochi R., Suemaru K., Kawasaki H., Araki H., Acta Med. Okayama, 63, 273-280 (2009).
6. Morimoto T., Nagao H., Sano N., Takahashi M., Matsuda H., Epilepsia, 32, 289-293 (1991).
7. Morimoto T., Kida K., Nagao H., Yoshida K., Fukuda M., Takashima S., Brain Res. Dev. Brain Res., 84, 204-207 (1995).
8. Fukuda M., Morimoto T., Nagao H., Kida K., Brain Res. Dev. Brain Res., 104, 197-199 (1997).
9. Chu N. S., Epilepsia, 22, 85-94 (1981).
10. Fukuda M., Morimoto T., Suzuki Y., Shinonaga C., Ishida Y., Brain Dev., 29, 644-648 (2007).
11. Toba T., Kurosaki T., Ohta F., Tamai K., Ikegami H., Saitoh Y., Matsuka Y., Makino K., Asai T., Arerugi, 43, 113-119 (1994).
12. Jaishree J., Kumaresan S., Sudha S., David J., Kulkarni C., Pol. J. Pharmacol., 55, 559-564 (2003).
13. Amabeoku G. J., Gen. Pharmacol., 32, 365-372 (1999).
14. Czuczwar S. J., Chmielewska B., Turski W. A., Kleinrok Z., Neuropharmacology, 23, 159-163 (1984).
15. Gernert M., Löscher W., Eur. J. Pharmacol., 432, 35-41 (2001).
16. Jung M. E., Wallis C. J., Gatch M. B., Lal H., J. Pharmacol. Exp. Ther., 291, 576-582 (1999).
17. Wilks L., File S. E., Martin I. L., Psychopharmacology (Berlin), 93, 127-132 (1987).
18. Ray A., Gulati K., Anand S., Vijayan V. K., Indian J. Exp. Biol., 43, 849-853 (2005).
19. Biswas S., Poddar M. K., Methods Find. Exp. Clin. Pharmacol., 10, 747-749 (1988).
20. Morimoto T., Nagao H., Yoshimatsu M., Yoshida K., Matsuda H., Epilepsia, 34, 447-452 (1993).
21. Qu L., Leung L. S., J. Neurochem., 106, 2158-2169 (2008).
22. Qu L., Leung L. S., J. Neurosci. Res., 87, 2773-2785 (2009).